World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ANZCTR
Last refreshed on: 27 August 2018
Main ID:  ACTRN12617000885392
Date of registration: 16/06/2017
Prospective Registration: Yes
Primary sponsor: Zhila Javidi-Hosseinabad
Public title: Evaluating the efficacy of additional self-compassion or cognitive therapy for treatment of post-traumatic stress disorder (PTSD) and depressive disorders
Scientific title: Comparison of the efficacy of behavioural therapy augmented with either self-compassion or cognitive therapy for the treatment of PTSD and depressive disorders
Date of first enrolment: 3/07/2017
Target sample size: 58
Recruitment status: Completed
URL:  http://www.anzctr.org.au/ACTRN12617000885392.aspx
Study type:  Interventional
Study design:  Randomised controlled trial  Parallel
Phase:  Not Applicable
Countries of recruitment
Contacts
Key inclusion & exclusion criteria
Health Condition(s) or Problem(s) studied
Depressive disorders
PTSD
Intervention(s)
The intervention is a combined therapy protocol (self-compassion with behavioural therapies).

Self-compassion: Comprise techniques that, through regular monitored practice, are designed to improve self-compassion by inter-connecting the three main affect regulation systems (i.e., contentment-soothing, threat, and drive).

Behaviour therapies: will comprise either exposure therapy (which can be carried out in real situations (in-vivo), or through imagination, for PTSD) or behavioural activation (based on encouraging the client to engage in routine jobs, pleasurable, and important/necessary activities, for depression).

Description of the 12 sessions of the Experimental (Novel) Treatment for PTSD and Depressive Disorders:

Step 1: Screening & Planning for Sessions 1 & 2 for both PTSD and Depressive Disorders:

*Baseline measures: To be scored by client in waiting room prior to screening.

*Information sheet & Consent form: To be explained by therapist, to be read by client & if agreed to be signed by client prior to screening assessment.

*Initial screening at session1: Completion of the semi structure assessment tools; Discussing, planning & management risk/safety;

*Explaining the rationale for Novel Treatment for PTSD & Depressive Disorders include: To discuss the rationales for PTSD: Exposure-Based Therapies (EBTs) & Self-Compassion (SC) based interventions; To discuss the rationales for depressive disorders: Behavioural Activation (BA) & Self-Compassion (SC) based interventions

*Psychosocial history at session 2: Establishing problem and treatment goals; Therapy contract/sessions; Discussion hierarchy of anxiety & homework (from 30 to 60 mins and to practice the task for more than 3 days per week)

Step 2: Experimental Treatment from Sessions 3 to 11 for PTSD and Depressive Disorders:

*Securing the therapeutic relationship from session 3 to 11: Safety, engagement, & signposting to psychosocial supports.

*Psychoeducation from session 3 to 4: PTSD symptoms, processes, it relation to developmental stages & other traumas; Depression symptoms, processes, it relation to developmental stages & other stressors

*Collaborating on treatment sequencing from session 3 to 11: Each session is co-operative; the client is expected to be active & to try to generate solutions.

*Structure Agenda from session 3 to 11: To review the homework; To assess progress towards client’s goals; To discuss feedback on the previous session; To focus on one or two specific related issues; To plan new homework; To checking their safety; & To organize the next session.

*Behavioural therapies (BTs) for PTSD and Depression: EBTs from session 3 to 11for PTSD with graded in-vivo exposure to trauma in relation to interceptive cues and avoidances behaviours; & graded imaginal exposure to trauma memory (i.e., written, verbal and/or recording). BA from session 3 to 11 for Depression: Describe and plan activity scheduling (AS) with client; To structure client’s day according to activities (i.e., routine, necessary & pleasurable) that are avoided; Clients are encouraged to start AS with short-term goals; & Clients learn to treat their AS, as a series of appointments with themselves.

*Self-Compassion (SC) based therapies from session 3 to 11 for PTSD: Threat/safety strategies; Formulation in Compassion Focused Therapy (CFT); Fear-based hotspots; Initial re-living identification based on shame & disgust; Building a compassionate image; Compassionate mind training; Critical voice & SC thought record sheet (therapist & client guides); Practice of meditation by Paul Gilbert and/or Kristina Neff from Mindful Self-Compassion (MSC); Developing inner qualities of inner compassion; Compassionate letter writing. SC based interventions from session 3 to 11 for Depression: Formulation in Compassion Focused Therapy (CFT); Building a compassionate image; Compassionate mind training; Critical voice & SC thought record sheets; Practice of meditation by Paul Gilbert and /or Kristina Neff from Mindful Self-Compassion (MSC); Developing inner qualities of inner compassion; Healthy emotion regulation strategies; Compassionate letter writing to self (therapist & client guides); Exercises to increase SC.

*Relapse prevention strategies from session 10 to 11 for PTSD and Depression.

Step 3: End of active treatment/ Discharge at session 12 for PTSD & Depressive Disorders:

*Review progress; Scoring the initial problem and goals; Summary & maintaining changes & gains from therapy; Blueprint & re-capping relapse prevention strategies; Follow-up sessions.

*Outcome Measures: To be scored by client at the end of the session 12.


As part of the protocol CARD for both Novel and Standard treatments: Clients diagnosed with PTSD work in collaboration with their therapist to establish their graded exposure tasks ( for 30 to 60 mins per day for more than 3 days) for in-vivo and imaginal. As part of the agreement between the the
Primary Outcome(s)
Secondary Outcome(s)
Secondary ID(s)
Source(s) of Monetary Support
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history